GleamWall
中文EN

CNXU Conexeu Sciences Inc.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 2066836 · Fiscal year ends 10/31

Financial factors as of 2026-07-31 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA—
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets18.2%
Debt / equity0.00x
Current ratio5.31x
Interest coverage—

Cash quality & payout

Operating cash flow / net income—
Accruals ratio—
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-07-312026Q22026-04-302025Q32025-07-312025Q22025-04-30
Income statement
Revenue————
R&D expense$270,412$66,605$134,662$42,465
SG&A expense$34,647$16,867$1,282$5,720
Operating income-$7.69M-$2.38M-$1.30M-$456,981
Interest expense$0$0-$43$1,383
Pretax income-$7.73M-$2.30M-$1.30M-$458,050
Income tax$0$0$0$0
Net income-$7.73M-$2.30M-$1.30M-$458,050
EBITDA-$7.68M-$2.37M-$1.29M-$453,580
EPS (basic)-0.29-0.11-0.09-0.05
EPS (diluted)-0.29-0.11-0.09-0.05
Weighted avg. shares (diluted)26.97M20.57M14.10M9.51M
Balance sheet
Cash & equivalents$1.97M$6.85M$833,128$79,436
Current assets$6.76M$7.91M——
PP&E, net$74,318$38,400——
Intangibles$163,996$163,949——
Total assets$7.16M$8.20M——
Current liabilities$1.27M———
Total liabilities$1.31M$1.00M——
Shareholders' equity$5.85M$7.20M$1.65M$176,745
Shares outstanding27.40M20.92M——
Cash flow statement
Operating cash flow-$6.76M—-$573,805—
Capital expenditure$41,400—$400—
Free cash flow-$6.80M—-$574,205—
Investing cash flow-$41,400—-$40,786—
Financing cash flow$1.70M—$1.37M—
Depreciation & amortization$5,435$11,422$6,640$3,401
Stock-based compensation$1.04M—-$64,311—

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.